Detailansicht

Wissensnetz

Person

Jörn Hilfrich (1941-)

Arzt

Name	Jörn Hilfrich
Zeit	1941- (Lebensdaten)
Ort	Hannover (Wirkungsort) Deutschland
Geschlecht	männlich
Akademischer Grad bzw. Titel	Prof. Dr. med.
Beruf	Arzt (charakteristischer Beruf) Gynäkologe
Variante	Jörn Wilhelm Hilfrich
Datensatztyp	Person
GND-Nummer	1271308592
Datensatz-ID	1271308592
Beteiligt an alle anzeigen Post-Mastectomy Radiotherapy After Neoadjuvant Chemotherapy in Breast Cancer: A Pooled Retrospective Analysis of Three Prospective Randomized Trials Post-mastectomy radiotherapy after neoadjuvant chemotherapy in breast cancer: a pooled retrospective analysis of three prospective randomized trials Outcome after neoadjuvant chemotherapy in young breast cancer patients: a pooled analysis of individual patient data from eight prospectively randomized controlled trials Impact of body mass index on neoadjuvant treatment outcome: a pooled analysis of eight prospective neoadjuvant breast cancer trials Response and prognosis after neoadjuvant chemotherapy in 1,051 patients with infiltrating lobular breast carcinoma Zurich Consensus: Statement of German Experts on St. Gallen Conference 2011 on Primary Breast Cancer (Zurich 2011) Impact of treatment characteristics on response of different breast cancer phenotypes: pooled analysis of the German neo-adjuvant chemotherapy trials Monitoring serum HER2 levels during neoadjuvant trastuzumab treatment within the GeparQuattro trial Zurich Consensus: German Expert Opinion on the St. Gallen Votes on 15 March 2009 (11th International Conference at St. Gallen: Primary Therapy of Early Breast Cancer) Clinical response after two cycles compared to HER2, Ki-67, p53, and bcl-2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breast A multicentre phase II study on gefitinib in taxane- and anthracycline-pretreated metastatic breast cancer Therapie des metastasierten Mammakarzinoms : Sitzungsprotokoll zum 3. Herceptin-Expertenworkshop, Bühlerhöhe, 7. - 9. September 2001 Experimentelle Untersuchungen über die karzinogene Wirkung von 7,12-Dimethylbenz(a)anthracen am Ovargewebe der Ratte und Maus : ein neues Modell zur Induktion maligner Ovarialtumoren bei der Ratte Bestimmung des Gehaltes an lactotropem Hormon im Serum von Frauen unter der Geburt und post partum unter Verwendung des Taubenkropftestes nach Grosvenor und Turner

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Jörn Hilfrich (1941-)

Post-Mastectomy Radiotherapy After Neoadjuvant Chemotherapy in Breast Cancer: A Pooled Retrospective Analysis of Three Prospective Randomized Trials

Post-mastectomy radiotherapy after neoadjuvant chemotherapy in breast cancer: a pooled retrospective analysis of three prospective randomized trials

Outcome after neoadjuvant chemotherapy in young breast cancer patients: a pooled analysis of individual patient data from eight prospectively randomized controlled trials

Impact of body mass index on neoadjuvant treatment outcome: a pooled analysis of eight prospective neoadjuvant breast cancer trials

Response and prognosis after neoadjuvant chemotherapy in 1,051 patients with infiltrating lobular breast carcinoma

Zurich Consensus: Statement of German Experts on St. Gallen Conference 2011 on Primary Breast Cancer (Zurich 2011)

Impact of treatment characteristics on response of different breast cancer phenotypes: pooled analysis of the German neo-adjuvant chemotherapy trials

Monitoring serum HER2 levels during neoadjuvant trastuzumab treatment within the GeparQuattro trial

Zurich Consensus: German Expert Opinion on the St. Gallen Votes on 15 March 2009 (11th International Conference at St. Gallen: Primary Therapy of Early Breast Cancer)

Clinical response after two cycles compared to HER2, Ki-67, p53, and bcl-2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breast

A multicentre phase II study on gefitinib in taxane- and anthracycline-pretreated metastatic breast cancer

Therapie des metastasierten Mammakarzinoms : Sitzungsprotokoll zum 3. Herceptin-Expertenworkshop, Bühlerhöhe, 7. - 9. September 2001

Experimentelle Untersuchungen über die karzinogene Wirkung von 7,12-Dimethylbenz(a)anthracen am Ovargewebe der Ratte und Maus : ein neues Modell zur Induktion maligner Ovarialtumoren bei der Ratte

Bestimmung des Gehaltes an lactotropem Hormon im Serum von Frauen unter der Geburt und post partum unter Verwendung des Taubenkropftestes nach Grosvenor und Turner